TCTAP 2024 Sponsors

Organon Korea

Logo
  • Address: Office #04-100 to #04-137, Level 4, WeWork Gwanghwamun, 50 Jong-ro 1-gil, Jongno-gu, Seoul 3142, Sou
  • Website: www.organon.com/korea/
We are a global healthcare company with a portfolio of therapies and products in womens health, biosimilars, and established brands across a wide array of conditions and diseases.
Our portfolio encompasses more than 60 medicines and products across a range of areas including reproductive health, heart disease, oncology, immunology, dermatology, allergy, and asthma. We bring these important therapies to more than 140 markets around the world.

Exhibition Item

Atozet

Satellite Symposium

Lunchtime Activities

Latest Trends in Dyslipidemia Management for Very High-risk ASCVD Patients

Organized by CVRF and Supported by Educational Grant from Organon Korea

Friday, April 26
12:45 PM ~ 1:45 PM * KST (UTC/GMT +9:00)
Presentation Room 2, Level 1
12:45 PM Recent Trends and Clinical Evidence for Optimizing Lipid Management : A Focus on Ezetimibe Combination Therapy
Lecturer: Ju Yeol Baek
1:05 PM High-dose Atorvastatin and Ezetimibe Combination for Treatment of Dyslipidemia Patients with ASCVD
Lecturer: Gyu-Chul Oh
1:25 PM Discussion

Lunchtime Activities

Lower for Longer: Reframing the Clinical Goal for LDL-C

Organized by CVRF and Supported by Educational Grant from Organon Korea

Saturday, April 27
12:45 PM ~ 1:45 PM * KST (UTC/GMT +9:00)
Presentation Room 1, Level 1
Moderator(s): Young-Guk Ko, Bon-Kwon Koo
12:45 PM What are the Real-world Issue to Keep LDL-C Lower for Longer
Lecturer: Seok-Jae Hwang
1:05 PM How Do We Achieve Lower for Longer LDL-C Levels for Patients
Lecturer: Sang Don Park
1:25 PM Discussion